\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes EIC EIE EITNote that there has been a reshuffle of responsibilities of the NCP Flanders Advisors that takes effect as of now, November 2024.
This reshuffle has an impact on several subdomains under Horizon Europe Pillar III 'Innovative Europe'.
The following NCP Advisors now stand ready to support you on the European Innovation Council (EIC), European Innovation Ecosystems (EIE) and the European Institute for Innovation & Technology (EIT):
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
